Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by dshah  – India, 2022-03-29 20:40 (1115 d 12:35 ago) – Posting: # 22884
Views: 3,105

Dear Balakotu!
As per EMA- In parallel design studies, the treatment groups should be comparable in all known variables that may affect the pharmacokinetics of the active substance (e.g. age, body weight, sex, ethnic origin, smoking status, extensive/poor metabolic status). This is an essential pre-requisite to give validity to the results from such studies.
In general, it is recommended to have balanced between treatment arms.
Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,710 registered users;
33 visitors (0 registered, 33 guests [including 8 identified bots]).
Forum time: 09:16 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5